Photochromic compounds
    3.
    发明授权
    Photochromic compounds 有权
    光致变色化合物

    公开(公告)号:US07582749B2

    公开(公告)日:2009-09-01

    申请号:US11925044

    申请日:2007-10-26

    摘要: Various non-limiting embodiments disclosed herein relate generally to photochromic compounds, which may be thermally reversible or non-thermally reversible, and articles made therefrom. Other non-limiting embodiments relate to photochromic-dichroic compounds, which may be thermally reversible or non-thermally reversible, and articles made therefrom. For example, one non-limiting embodiment provides a thermally reversible, photochromic compound adapted to have at least a first state and a second state, wherein the thermally reversible, photochromic compound has an average absorption ratio greater than 2.3 in at least one state as determined according to CELL METHOD. Another non-limiting embodiment provides a photochromic compound comprising: (a) at least one photochromic group chosen from a pyran, an oxazine, and a fulgide; and (b) at least one lengthening agent L attached to the at least one photochromic group and represented by the formula—[S1]c-[Q1 —[S2]d]d′-[Q2 —[S3]e]e′-[Q3 —[S4]f]f′—S5—P, which is described herein.

    摘要翻译: 本文公开的各种非限制性实施方案通常涉及光致变色化合物,其可以是热可逆的或不可逆的,以及由其制成的制品。 其它非限制性实施方案涉及光致变色二色性化合物,其可以是热可逆的或不可逆的,以及由其制备的制品。 例如,一个非限制性实施方案提供了适于具有至少第一状态和第二状态的热可逆的光致变色化合物,其中所述热可逆的光致变色化合物在至少一种状态中的平均吸收比大于2.3,如所确定的 根据细胞方法 另一个非限制性实施方案提供了一种光致变色化合物,其包含:(a)至少一种选自吡喃,恶嗪和吡啶的光致变色基团; 由式 - [S1] c- [Q1- [S2] d] d' - [Q2- [S3] e] e'表示的至少一个延长剂L连接到至少一个光致变色基团上, - [Q3 - [S4] f] f'-S5-P,这里描述。

    Polarizing, photochromic devices and methods of making the same
    8.
    发明申请
    Polarizing, photochromic devices and methods of making the same 有权
    偏光,光致变色装置及制作方法

    公开(公告)号:US20050012998A1

    公开(公告)日:2005-01-20

    申请号:US10846650

    申请日:2004-05-17

    摘要: Various embodiments disclosed herein relate to optical elements comprising an at least partial coating having a first state and a second state connected to at least a portion of a substrate, the at least partial coating being adapted to switch from the first state to the second state in response to at least actinic radiation, to revert back to the first state in response to thermal energy, and to linearly polarize at least transmitted radiation in at least one of the first state and the second state. Other embodiments relate to optical elements comprising a substrate and at least one at least partially aligned photochromic-dichroic compound connected to at least a portion of the substrate and having an average absorption ratio greater than 2.3 in the activated state as determined according to CELL METHOD. Still other embodiments relate to security devices, liquid crystal cells and methods of making the same.

    摘要翻译: 本文公开的各种实施例涉及包括具有连接到基板的至少一部分的第一状态和第二状态的至少部分涂层的光学元件,所述至少部分涂层适于从第一状态切换到第二状态 对至少光化辐射的响应,响应于热能回复到第一状态,并且至少在第一状态和第二状态中的至少一个之间线性偏振至少透射的辐射。 其它实施方案涉及包含基材和至少一种至少部分排列的光致变色二色性化合物的光学元件,所述光致变色二色性化合物连接至所述基材的至少一部分,并且在根据CELL METHOD测定的激活状态下具有大于2.3的平均吸收比。 其他实施例涉及安全装置,液晶盒及其制造方法。

    Photochromic compounds
    9.
    发明申请
    Photochromic compounds 有权
    光致变色化合物

    公开(公告)号:US20050004361A1

    公开(公告)日:2005-01-06

    申请号:US10846629

    申请日:2004-05-17

    摘要: Various non-limiting embodiments disclosed herein relate generally to photochromic compounds, which may be thermally reversible or non-thermally reversible, and articles made therefrom. Other non-limiting embodiments relate to photochromic-dichroic compounds, which may be thermally reversible or non-thermally reversible, and articles made therefrom. For example, one non-limiting embodiment provides a thermally reversible, photochromic compound adapted to have at least a first state and a second state, wherein the thermally reversible, photochromic compound has an average absorption ratio greater than 2.3 in at least one state as determined according to CELL METHOD. Another non-limiting embodiment provides a photochromic compound comprising: (a) at least one photochromic group chosen from a pyran, an oxazine, and a fulgide; and (b) at least one lengthening agent L attached to the at least one photochromic group and represented by the formula —[S1]c-[Q1-[S2]d]d′-[Q2-[S3]e]e′-[Q3-[S4]f]f′—S5—P, which is described herein.

    摘要翻译: 本文公开的各种非限制性实施方案通常涉及光致变色化合物,其可以是热可逆的或不可逆的,以及由其制成的制品。 其它非限制性实施方案涉及光致变色二色性化合物,其可以是热可逆的或不可逆的,以及由其制备的制品。 例如,一个非限制性实施方案提供了适于具有至少第一状态和第二状态的热可逆的光致变色化合物,其中所述热可逆的光致变色化合物在至少一种状态中的平均吸收比大于2.3,如所确定的 根据细胞方法 另一个非限制性实施方案提供了一种光致变色化合物,其包含:(a)至少一种选自吡喃,恶嗪和吡啶的光致变色基团; 由式 - [S1] c- [Q1- [S2] d] d' - [Q2- [S3] e] e'表示的至少一个延长剂L连接到至少一个光致变色基团上, - [Q3- [S4] f] f'-S5-P,其在本文中描述。